🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

Recruitingn/aAges 18 Years - anyAllUniversity Hospital, Tours
NCT07444853 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study. The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ≥ 18 years; * Emergency admission to a participating center, with spontaneous intracerebral hemorrhage confirmed by the first brain imaging (CT or MRI) performed at the time of initial treatment; * Obtaining non-opposition Exclusion Criteria: * First brain imaging performed outside a center participating in the study (e.g., peripheral center not recruiting); * Intracerebral hemorrhage secondary to another identified condition, including: * vascular malformation (aneurysm, arteriovenous malformation, cavernoma, etc.); * intracranial tumor; * hemorrhagic transformation of a cerebral infarction; * recent head trauma. * Patient under legal protection; * Patient under guardianship or conservatorship.
💊

What it tests

  • Not listed
📍

Where

4 sites
university hospital, Angers
Angers, France
university hospital, Lille
Lille, France
University hospital, Toulouse
Toulouse, France
University hospital
Tours, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy